Our selection of exosomal biomarkers includes three miRNAs (miR-19b, miR-21, miR-145), previously identified as potential diagnostic biomarkers and two clinically applied conventional protein tumor biomarkers, CEA and CYFRA21. Here, CEACAM5 is linked to neoplasm.